Tracey L Freeman Selected Research

4,4,',4'',4'''- (carbonylbis(imino- 5,1,3- benzenetriylbis(carbonylimino)))tetrakis(benzene- 1,3- disulfonate)

1/2020

P2X1 Selective Antagonists Block HIV-1 Infection through Inhibition of Envelope Conformation-Dependent Fusion.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tracey L Freeman Research Topics

Disease

1	COVID-19 01/2020
1	Infections 01/2020
1	Respiratory Insufficiency (Respiratory Failure) 01/2020

Drug/Important Bio-Agent (IBA)

1	4,4,',4'',4'''- (carbonylbis(imino- 5,1,3- benzenetriylbis(carbonylimino)))tetrakis(benzene- 1,3- disulfonate)IBA 01/2020
1	NF 279IBA 01/2020
1	3- (5- (2,3- dichlorophenyl)- 1H- tetrazol- 1- yl)methylpyridineIBA 01/2020
1	Broadly Neutralizing AntibodiesIBA 01/2020
1	CytokinesIBA 01/2020
1	Purinergic P2X1 ReceptorsIBA 01/2020
1	InflammasomesIBA 01/2020